Insights

Strategic partnerships Active Iron has recently partnered with a leading menstrual health app, Clue, to offer free access. Potential sales opportunity: co-marketing and bundled health solutions with digital health platforms and women’s health services to expand market reach and drive trust.

Global footprint Active Iron is available in 12 markets worldwide, indicating established regulatory and distribution capabilities. Potential sales opportunity: leverage existing international presence to cross-sell related iron deficiency and pregnancy support products, and pursue new country launches through partners or distributors.

Clinical edge Product platform delivers better iron absorption with fewer gastrointestinal side effects versus ferrous sulfate. Potential sales opportunity: position to clinicians and pharmacists as a safer, patient-friendly oral iron option in both general hematology and obstetrics/gynaecology clinical pathways.

R&D collaboration R&D is conducted with academic partners (Trinity College Dublin) and patent-protected platforms. Potential sales opportunity: explore co-development or research licenses for expanded indications, in-licensing conversations with larger pharma for downstream formulations or combination therapies.

Financial levers Company operates with a lean team and modest revenue with substantial funding backing. Potential sales opportunity: engage in pilot programs, channel partnerships, or contract manufacturing agreements to scale distribution while aligning with investors’ growth expectations.

Similar companies to Solvotrin Therapeutics - Active Iron

Solvotrin Therapeutics - Active Iron Tech Stack

Solvotrin Therapeutics - Active Iron uses 8 technology products and services including Microsoft Clarity, Amazon Web Services, Cloudinary, and more. Explore Solvotrin Therapeutics - Active Iron's tech stack below.

Solvotrin Therapeutics - Active Iron's Email Address Formats

Solvotrin Therapeutics - Active Iron uses at least 4 email formats:
Solvotrin Therapeutics - Active Iron Email FormatsExamplePercentage
FirstLast@solvotrin.comJohnDoe@solvotrin.com
77%
FirstMLast@solvotrin.comJohnMDoe@solvotrin.com
8%
FLast@solvotrin.comJDoe@solvotrin.com
7%
FirLast@solvotrin.comJohDoe@solvotrin.com
8%

Frequently Asked Questions

What is Solvotrin Therapeutics - Active Iron's official website and social media links?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron's official website is activeiron.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Solvotrin Therapeutics - Active Iron generate?

Minus sign iconPlus sign icon
As of July 2026, Solvotrin Therapeutics - Active Iron's annual revenue is estimated to be <$1M.

What is Solvotrin Therapeutics - Active Iron's NAICS code?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Solvotrin Therapeutics - Active Iron have currently?

Minus sign iconPlus sign icon
As of July 2026, Solvotrin Therapeutics - Active Iron has approximately 21 employees across 1 continents, including Europe. Key team members include Ceo: P. O. F., Chief Financial Officer: G. W. and Chief Operating Officer: R. M. Explore Solvotrin Therapeutics - Active Iron's employee directory with LeadIQ.

What industry does Solvotrin Therapeutics - Active Iron belong to?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron operates in the Pharmaceutical Manufacturing industry.

What technology does Solvotrin Therapeutics - Active Iron use?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron's tech stack includes Microsoft Clarity, Amazon Web Services, Cloudinary, CookieYes, Microsoft 365, Mautic, Trustpilot and Apple Pay.

What is Solvotrin Therapeutics - Active Iron's email format?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron's email format typically follows the pattern of FirstLast@solvotrin.com. Find more Solvotrin Therapeutics - Active Iron email formats with LeadIQ.

How much funding has Solvotrin Therapeutics - Active Iron raised to date?

Minus sign iconPlus sign icon
As of July 2026, Solvotrin Therapeutics - Active Iron has raised $15M in funding. The last funding round occurred on Nov 02, 2020 for $7.8M.

When was Solvotrin Therapeutics - Active Iron founded?

Minus sign iconPlus sign icon
Solvotrin Therapeutics - Active Iron was founded in 2009.
Solvotrin Therapeutics - Active Iron logo

Solvotrin Therapeutics - Active Iron

Pharmaceutical ManufacturingCork, Ireland11-50 Employees

Solvotrin Therapeutics - Active Iron is an Irish pharmaceutical development company that focuses on optimizing established therapies through science and patent protection. Headquartered in Cork, County Cork, Ireland, the company operates as a small to mid-sized team with R&D activities conducted at Trinity College Dublin. Its flagship Active platform supports a family of oral iron products marketed under the Active Iron brand, which is distributed in several markets worldwide. Solvotrin has developed two patent-protected platforms with applications across a range of medical settings. A recent development occurred in October 2024 when Active Iron announced a partnership with Clue, a popular menstrual health app, to provide free access to its users.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $15M

    Solvotrin Therapeutics - Active Iron has raised a total of $15M of funding over 4 rounds. Their latest funding round was raised on Nov 02, 2020 in the amount of $7.8M as a Venture Round.

  • <$1M

    Solvotrin Therapeutics - Active Iron's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.